Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells
暂无分享,去创建一个
R. Qin | C. Peng | Chengjian Shi | Min Wang | R. Tian | Zhi-yong Du | Cuifeng Wei | Rui Tian | Chenghong Peng
[1] H. Ling. Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma:A Qualitative Systematic Review , 2010 .
[2] A. Ghanate,et al. Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.
[3] Zhiwei Wang,et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. , 2009, Cancer research.
[4] D. Simeone. Pancreatic Cancer Stem Cells: Implications for the Treatment of Pancreatic Cancer , 2008, Clinical Cancer Research.
[5] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[6] M. Krause,et al. Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.
[7] D. Simeone,et al. Pancreatic cancer stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Sonenshein,et al. NF‐κB and epithelial to mesenchymal transition of cancer , 2008, Journal of cellular biochemistry.
[9] Curt Balch,et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.
[10] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[11] U. Lendahl,et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.
[12] J. Thiery,et al. The physiology and pathology of the EMT Meeting on the Epithelial – Mesenchymal Transition , 2008 .
[13] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[14] R. Hromas,et al. Oct‐4 Is Critical for Survival/Antiapoptosis of Murine Embryonic Stem Cells Subjected to Stress: Effects Associated with Stat3/Survivin , 2008, Stem cells.
[15] R. Qin,et al. siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity , 2008, Digestive Diseases and Sciences.
[16] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[17] P. Stern,et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. , 2007, Cancer research.
[18] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[19] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[20] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[21] B. Alman,et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. , 2007, Cancer research.
[22] H. Kajiyama,et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. , 2007, International journal of oncology.
[23] I. Han,et al. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. , 2007, European journal of cancer.
[24] M. Bissell,et al. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. , 2007, Cancer research.
[25] G. Gallick,et al. Src, chemoresistance and epithelial to mesenchymal transition: are they related? , 2007, Anti-cancer drugs.
[26] C. Iacobuzio-Donahue,et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.
[27] O. Ammerpohl,et al. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. , 2007, Hepatobiliary & pancreatic diseases international : HBPD INT.
[28] P. Dalerba,et al. Identification of pancreatic cancer stem cells. , 2006, Cancer research.
[29] J. Ruppert,et al. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. , 2007, Oncogene.
[30] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[31] K. Black,et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.
[32] J. Soria,et al. Tumour stem cell-targeted treatment: elimination or differentiation. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] L. Ellis,et al. Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines , 2006, Clinical Cancer Research.
[34] Tetsuhiro Chiba,et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties , 2006, Hepatology.
[35] R. Qin,et al. Effect of Antisense Hypoxia-inducible Factor 1&agr; on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer , 2006, Pancreas.
[36] T. Utsunomiya,et al. Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System , 2006, Stem cells.
[37] R. Nicholson,et al. Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation , 2006, International journal of cancer.
[38] S. Miyatake,et al. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. , 2005, Surgery.
[39] C. Rödel,et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. , 2005, Cancer research.
[40] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[41] M. Kumar,et al. Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts. , 2005, World journal of gastroenterology.
[42] L. Olson,et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. , 2004, Carcinogenesis.
[43] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[44] S. Miyatake,et al. Survivin expression is a prognostic marker in pancreatic cancer patients. , 2004, Surgery.
[45] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[46] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[48] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.